Screening program for prostate cancer at a university hospital in eastern Saudi Arabia

Saudi Medical Journal

Volumn 26, Issue 7, 2005, Pages 1104-1106

  Taha, Saud A ^a   Kamal, Baher A ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; ECHOGRAPHY; HEALTH PROGRAM; HUMAN; INTESTINE EXAMINATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OUTPATIENT DEPARTMENT; PILOT STUDY; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; SAUDI ARABIA; TRANSRECTAL ULTRASONOGRAPHY; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; HOSPITALS, UNIVERSITY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PALPATION; PILOT PROJECTS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SAUDI ARABIA;

EID: 24044491569     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Schroder FH. Screening for prostate cancer. Urol Clin North Am 2003; 30: 239-251.
2. Pienta KJ. Etiology, epidemiology and prevention of carcinoma of the prostate. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's Urology. Philadelphia, Pennsylvania: WB Saunders Company; 1998. p. 2489-2496.
3. Mosli HA. Prostate cancer in Saudi Arabia in 2002. Saudi Med J 2003; 24: 573-581.
4. Mosli HA. Prostate Cancer in Saudi Arabia. Review of the Literature (1975-1996). Ann Saudi Med 1997; 17: 510-514.
5. Al Jasser A, Rifai G, Kassas H. Screening for prostate Carcinoma. Proceeding of the 9th Saudi Urological Conference; 1995 Nov 14-15; King Fahd Hospital, Jeddah, KSA: 1995.
6. Ghali AM, El Malik EMA, Ibrahim AIA, Murad N, Al Gizawi A. Clinical Features and Surgical Outcome of Benign Prostatic hyperplasia. Ann Saudi Med 1996; 2: 166-170.
7. Mosh HA. Incidental Adenocarcinoma of the Prostate Carcinoma. Proceeding of the 9th Saudi Urological Conference; 1995 Nov 14-15; King Fahd Hospital, Jeddah, KSA: 1995.
8. Al Zahrani H, Onura V, Al-Jawini N, Al-Turki M, Koko AM, Mobed A. Incidental Adenocarcinoma of the Prostate in Saudi Arabians Undergoing Prostatectomy for BPH. Proceedings of the 12th Saudi Urological Conference; 1999 Feb 23-25; Al-Hada, KSA. Taif: Al-Mashhoury Press: 1999.
9. Al Otaibi KM, Al-Tartir T, Trabulsi FM. Predictive Parameters in Screening for Prostate Cancer. Proceedings of the 14th Saudi Urological Conference; 2001 Feb 13-15; King Fahd Military Medical Complex, Al-Khobar, KSA: 2001.
10. Al Otaibi KM. Screening for prostate cancer. Proceedings of the 16th Saudi Urological Conference; 2004 March 2-4, King Faisal Specialist Hospital, Riyadh, KSA: 2004.
11. Nelen V, Neelss H, Neetens I, Coebergh J, Dourcy-Belle-Rose B, Denis L. ERSPC features and preliminary results from the Antwerp study centre. BJU Int 2003; 92 (suppl 2): 17-21.
12. Finne P, Stenman U, Maattanen L, Makinen T, Tammela TLJ, Martikainen P, et al. The Finish Trial of prostate cancer screening: where are we now? BJU Int 2003; 92 (suppl 2): 22-26.
13. Villers A, Malavaud B, Rebillard X, Bataille V, Iborra F. ERSPC: features and preliminary results of France. BJU Int 2003; 92 (suppl 2): 27-29.
14. Ciatto S, Gervasi G, Frullini P, Zendoren P, Zappa M. Specific features of the Italian section of ERSPC. BJU Int 2003; 92 (suppl 2): 30-32.
15. Berenguer A, Lujan M, Paez A, Santonja C, Pascula. T. Spanish contribution to the European Randomized Study of Screening for Prostate Cancer. BJU Int 2003; 92 (suppl 2): 33-38.
16. Hugosson J, Aus G, Bergdahl S, Fernlund P, Frosing R, Lodding P, et al. Population-based Screening for prostate cancer by measuring free and total Serum prostate-specific antigen in Sweeden. BJU Int 2003; 92 (suppl 2): 39-43.
17. Kwiatkowski M, Huber A, Stamm B, Lehmann K, Wernli M, Hafeli A, et al. Features and preliminary results of prostate cancer screening in Canton, Switzerland. BJU Int 2003; 92 (suppl 2): 44-47.
18. Roobol MJ, Kirkels WJ, Schroder FH. Features and preliminary results of the Dutch center of the ERSPC. BJU Int 2003; 92 (suppl 2): 48-54.
19. Catalona WJ, Smith DS, Ratliff TL. Measurements of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156-1161.
20. Schroder FH, Boyle P. Screening for Prostate Cancer necessity or nonsense? Eur J Cancer 1993; 29A: 656-661.
21. Denis LJ, Murphy GP, Schroder FH. Report of the consensus workshop on screening and global strategy for prostate cancer. Cancer 1995; 75: 1187-1207.
22. Murphy G, Griffiths K, Denis L, Khoury S, Chatelain C, Cockettt AT, et al. First International Consultation on Prostate Cancer: Manchecourt: WHO and UICC, 1997.
23. US Preventive Services Task Force. Screening for P.C.: Recommendation and Rationale. Ann Intern Med 2002; 137: 9156.
24. American Urological Association. Prostate-Specific Antigen (PSA) Best Practice Policy. Oncology 2002; 14: 267-272.
25. Smith RA, Cokkidines V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer. CA Cancer J Clin 2003; 53: 27-43.